Insulin neuroprotection and the mechanisms

Chinese Medical Journal

Volumn 128, Issue 7, 2015, Pages 976-981

  Yu, Li Yun ^a   Pei, Yu ^b  

^a BEIJING ELECTRIC POWER HOSPITAL   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Blood glucose; Brain ischemia; Insulin; Neuroprotection

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; EXCITATORY AMINO ACID TRANSPORTER 1; GLUCOSE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; GLYCOGEN; INSULIN; LACTIC ACID; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NEUROTRANSMITTER; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C; GLUCOSE BLOOD LEVEL; NEUROPROTECTIVE AGENT;

ANTIDIABETIC ACTIVITY; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; GLUCOSE BLOOD LEVEL; GLUCOSE BRAIN LEVEL; GLYCOGEN METABOLISM; GLYCOGEN SYNTHESIS; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MICRODIALYSIS; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TRAUMATIC BRAIN INJURY; DRUG EFFECTS;

BLOOD GLUCOSE; BRAIN ISCHEMIA; HUMANS; HYPERGLYCEMIA; INSULIN; NEUROPROTECTIVE AGENTS;

EID: 84929192433     PISSN: 03666999     EISSN: 25425641     Source Type: Journal    
DOI: 10.4103/0366-6999.154323     Document Type: Article

References (64)

1. Hui L, Pei DS, Zhang QG, Guan QH, Zhang GY. The neuroprotection of insulin on ischemic brain injury in rat hippocampus through negative regulation of JNK signaling pathway by PI3K/Akt activation. Brain Res 2005;1052:1-9.
2. Voll CL, Auer RN. Insulin attenuates ischemic brain damage independent of its hypoglycemic effect. J Cereb Blood Flow Metab 1991;11:1006-14.
3. Fanne RA, Nassar T, Heyman SN.: Hijazi N, Higazi AA. Insulin and glucagon share the same mechanism of neuroprotection in diabetic rats: Role of glutamate. Am J Physiol Regul Integr Comp Physiol 2011;301:R668-73.
4. Mielke JG, Wang YT. Insulin exerts neuroprotection by counteracting the decrease in cell-surface GABA receptors following oxygen-glucose deprivation in cultured cortical neurons. J Neurochem 2005;92:103-13.
5. Smith QR. Transport of glutamate and other amino acids at the blood-brain barrier. J Nutr 2000;130:1016S-22.
6. Gomes JR, Lobo AC, Melo CV, Inácio AR, Takano J, Iwata N, et al. Cleavage of the vesicular GABA transporter under excitotoxic conditions is followed by accumulation of the truncated transporter in nonsynaptic sites. J Neurosci 2011;31:4622-35.
7. Hawkins RA. The blood-brain barrier and glutamate. Am J Clin Nutr 2009;90:867S-74.
8. Bullock R, Zauner A, Woodward J, Young HF. Massive persistent release of excitatory amino acids following human occlusive stroke. Stroke 1995;26:2187-9.
9. Gwag BJ, Koh JY, DeMaro JA, Ying HS, Jacquin M, Choi DW. Slowly triggered excitotoxicity occurs by necrosis in cortical cultures. Neuroscience 1997;77:393-401.
10. Kim SJ, Han Y. Insulin inhibits AMPA-induced neuronal damage via stimulation of protein kinase B (Akt). J Neural Transm 2005;112:179-91.
11. Zhuravliova E, Barbakadze T, Narmania N, Sepashvili M, Mikeladze DG. Hypoinsulinemia alleviates the GRF1/Ras/Akt anti-apoptotic pathway and induces alterations of mitochondrial ras trafficking in neuronal cells. Neurochem Res 2009;34:1076-82.
12. Jin Z, Jin Y, Kumar-Mendu S, Degerman E, Groop L, Birnir B. Insulin reduces neuronal excitability by turning on GABA(A) channels that generate tonic current. PLoS One 2011;6:e16188.
13. Sherin A, Peeyush KT, Naijil G.: Chinthu R, Paulose CS. Hypoglycemia induced behavioural deficit and decreased GABA receptor, CREB expression in the cerebellum of streptozoticin induced diabetic rats. Brain Res Bull 2010;83:360-6.
14. Antony S, Kumar TP, Kuruvilla KP, George N, Paulose CS. Decreased GABA receptor binding in the cerebral cortex of insulin induced hypoglycemic and streptozotocin induced diabetic rats. Neurochem Res 2010;35:1516-21.
15. Vetiska SM, Ahmadian G, Ju W, Liu L, Wymann MP, Wang YT. GABAA receptor-associated phosphoinositide 3-kinase is required for insulin-induced recruitment of postsynaptic GABAA receptors. Neuropharmacology 2007;52:146-55.
16. Sun X, Yao H, Douglas RM, Gu XQ, Wang J, Haddad GG. Insulin/PI3K signaling protects dentate neurons from oxygen-glucose deprivation in organotypic slice cultures. J Neurochem 2010;112:377-88.
17. Shuaib A, Ijaz MS, Waqar T, Voll C, Kanthan R, Miyashita H, et al. Insulin elevates hippocampal GABA levels during ischemia. This is independent of its hypoglycemic effect. Neuroscience 1995;67:809-14.
18. Morgenthaler FD, Koski DM, Kraftsik R, Henry PG, Gruetter R. Biochemical quantification of total brain glycogen concentration in rats under different glycemic states. Neurochem Int 2006;48:616-22.
19. Heni M, Hennige AM, Peter A, Siegel-Axel D, Ordelheide AM, Krebs N, et al. Insulin promotes glycogen storage and cell proliferation in primary human astrocytes. PLoS One 2011;6:e21594.
20. Sickmann HM, Walls AB, Schousboe A, Bouman SD, Waagepetersen HS. Functional significance of brain glycogen in sustaining glutamatergic neurotransmission. J Neurochem 2009;109 Suppl 1:80-6.
21. Choi IY, Seaquist ER, Gruetter R. Effect of hypoglycemia on brain glycogen metabolism in vivo. J Neurosci Res 2003;72:25-32.
22. Suh SW, Bergher JP, Anderson CM, Treadway JL, Fosgerau K, Swanson RA. Astrocyte glycogen sustains neuronal activity during hypoglycemia: Studies with the glycogen phosphorylase inhibitor CP - 316,819 ([R-R*,S*]-5-chloro-N-[2-hydroxy-3- (methoxymethylami no)-3-oxo-1-(phenylmethyl) propyl] - 1H - indole - 2 - carboxamide). J Pharmacol Exp Ther 2007;321:45-50.
23. Brown AM, Tekkök SB, Ransom BR. Glycogen regulation and functional role in mouse white matter. J Physiol 2003;549:501-12.
24. Brown AM, Sickmann HM, Fosgerau K, Lund TM, Schousboe A, Waagepetersen HS, et al. Astrocyte glycogen metabolism is required for neural activity during aglycemia or intense stimulation in mouse white matter. J Neurosci Res 2005;79:74-80.
25. Wender R, Brown AM, Fern R, Swanson RA, Farrell K, Ransom BR. Astrocytic glycogen influences axon function and survival during glucose deprivation in central white matter. J Neurosci 2000;20:6804-10.
26. Allen NJ, Káradóttir R, Attwell D. A preferential role for glycolysis in preventing the anoxic depolarization of rat hippocampal area CA1 pyramidal cells. J Neurosci 2005;25:848-59.
27. Oz G, Seaquist ER, Kumar A, Criego AB, Benedict LE, Rao JP, et al. Human brain glycogen content and metabolism: Implications on its role in brain energy metabolism. Am J Physiol Endocrinol Metab 2007;292:E946-51.
28. Hamai M, Minokoshi Y, Shimazu T. L-Glutamate and insulin enhance glycogen synthesis in cultured astrocytes from the rat brain through different intracellular mechanisms. J Neurochem 1999;73:400-7.
29. Guyot LL, Diaz FG, O’Regan MH, Song D, Phillis JW. Topical insulin and accumulation of excitotoxic and other amino acids in ischemic rat cerebral cortex. Proc Soc Exp Biol Med 2000;224:28-31.
30. Choi IY, Gruetter R. In vivo 13C NMR assessment of brain glycogen concentration and turnover in the awake rat. Neurochem Int 2003;43:317-22.
31. Canada SE, Weaver SA, Sharpe SN, Pederson BA. Brain glycogen supercompensation in the mouse after recovery from insulin-induced hypoglycemia. J Neurosci Res 2011;89:585-91.
32. Prebil M, Vardjan N, Jensen J, Zorec R, Kreft M. Dynamic monitoring of cytosolic glucose in single astrocytes. Glia 2011;59:903-13.
33. Gentile NT, Seftchick MW, Huynh T, Kruus LK, Gaughan J. Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad Emerg Med 2006;13:174-80.
34. Oz G, Kumar A, Rao JP, Kodl CT, Chow L, Eberly LE, et al. Human brain glycogen metabolism during and after hypoglycemia. Diabetes 2009;58:1978-85.
35. Folbergrova J, Katsura KI, Siesjo BK. Glycogen accumulated in the brain following insults is not degraded during a subsequent period of ischemia. J Neurol Sci 1996;137:7-13.
36. Lanier WL, Hofer RE, Gallagher WJ. Metabolism of glucose, glycogen, and high-energy phosphates during transient forebrain ischemia in diabetic rats: Effect of insulin treatment. Anesthesiology 1996;84:917-25.
37. Davis LM, Pauly JR, Readnower RD, Rho JM, Sullivan PG. Fasting is neuroprotective following traumatic brain injury. J Neurosci Res 2008;86:1812-22.
38. Hamabe W, Fujita R, Ueda H. Insulin receptor-protein kinase C-gamma signaling mediates inhibition of hypoxia-induced necrosis of cortical neurons. J Pharmacol Exp Ther 2005;313:1027-34.
39. Hamabe W, Fujita R, Ueda H. Neuronal necrosis inhibition by insulin through protein kinase C activation. J Pharmacol Exp Ther 2003;307:205-12.
40. Kim B, Sullivan KA, Backus C, Feldman EL.: Cortical neurons develop insulin resistance and blunted Akt signaling: A potential mechanism contributing to enhanced ischemic injury in diabetes. Antioxid Redox Signal 2011;14:1829-39.
41. Sanderson TH, Kumar R, Murariu-Dobrin AC, Page AB, Krause GS, Sullivan JM. Insulin activates the PI3K-Akt survival pathway in vulnerable neurons following global brain ischemia. Neurol Res 2009;31:947-58.
42. Sanderson TH, Mahapatra G, Pecina P, Ji Q, Yu K, Sinkler C, et al. Cytochrome C is tyrosine 97 phosphorylated by neuroprotective insulin treatment. PLoS One 2013;8:e78627.
43. Ryu BR, Ko HW, Jou I, Noh JS, Gwag BJ. Phosphatidylinositol 3-kinase-mediated regulation of neuronal apoptosis and necrosis by insulin and IGF-I. J Neurobiol 1999;39:536-46.
44. Green DR. Apoptotic pathways: Paper wraps stone blunts scissors. Cell 2000;102:1-4.
45. Noh KM, Lee JC, Ahn YH, Hong SH, Koh JY. Insulin-induced oxidative neuronal injury in cortical culture: Mediation by induced N-methyl-D-aspartate receptors. IUBMB Life 1999;48:263-9.
46. Wang YY, Lin SY, Chuang YH, Sheu WH, Tung KC, Chen CJ. Activation of hepatic inflammatory pathways by catecholamines is associated with hepatic insulin resistance in male ischemic stroke rats. Endocrinology 2014;155:1235-46.
47. Harada S, Fujita WH, Shichi K, Tokuyama S. The development of glucose intolerance after focal cerebral ischemia participates in subsequent neuronal damage. Brain Res 2009;1279:174-81.
48. Park S, Kim da S, Kang S, Kwon DY. Ischemic hippocampal cell death induces glucose dysregulation by attenuating glucose-stimulated insulin secretion which is exacerbated by a high fat diet. Life Sci 2011;88:766-73.
49. Green DM, O’Phelan KH, Bassin SL, Chang CW, Stern TS, Asai SM. Intensive versus conventional insulin therapy in critically ill neurologic patients. Neurocrit Care 2010;13:299-306.
50. Bilotta F, Caramia R, Paoloni FP, Delfini R, Rosa G. Safety and efficacy of intensive insulin therapy in critical neurosurgical patients. Anesthesiology 2009;110:611-9.
51. Bilotta F, Caramia R, Cernak I, Paoloni FP, Doronzio A, Cuzzone V, et al. Intensive insulin therapy after severe traumatic brain injury: A randomized clinical trial. Neurocrit Care 2008;9:159-66.
52. Bilotta F, Spinelli A, Giovannini F, Doronzio A, Delfini R, Rosa G. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: A randomized prospective pilot trial. J Neurosurg Anesthesiol 2007;19:156-60.
53. Fukuoka S, Yeh H, Mandybur TI, Tew JM Jr. Effect of insulin on acute experimental cerebral ischemia in gerbils. Stroke 1989;20:396-9.
54. Collino M, Aragno M, Castiglia S, Tomasinelli C, Thiemermann C, Boccuzzi G, et al. Insulin reduces cerebral ischemia/reperfusion injury in the hippocampus of diabetic rats: A role for glycogen synthase kinase-3beta. Diabetes 2009;58:235-42.
55. Vespa P, Boonyaputthikul R, McArthur DL, Miller C, Etchepare M, Bergsneider M, et al. Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury. Crit Care Med 2006;34:850-6.
56. Oddo M, Schmidt JM, Carrera E, Badjatia N, Connolly ES, Presciutti M, et al. Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: A microdialysis study. Crit Care Med 2008;36:3233-8.
57. Béchir M, Meierhans R, Brandi G, Sommerfeld J, Fasshauer M, Cottini SR, et al. Insulin differentially influences brain glucose and lactate in traumatic brain injured patients. Minerva Anestesiol 2010;76:896-904.
58. Meierhans R, Béchir M, Ludwig S, Sommerfeld J, Brandi G, Haberthür C, et al. Brain metabolism is significantly impaired at blood glucose below 6 mM and brain glucose below 1 mM in patients with severe traumatic brain injury. Crit Care 2010;14:R13.
59. Vemula S, Roder KE, Yang T, Bhat GJ, Thekkumkara TJ, Abbruscato TJ. A functional role for sodium-dependent glucose transport across the blood-brain barrier during oxygen glucose deprivation. J Pharmacol Exp Ther 2009;328:487-95.
60. Zhu CZ, Auer RN. Optimal blood glucose levels while using insulin to minimize the size of infarction in focal cerebral ischemia. J Neurosurg 2004;101:664-8.
61. Gray CS, Hildreth AJ, Sandercock PA, O’Connell JE, Johnston DE, Cartlidge NE, et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: The UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 2007;6:397-406.
62. Scott JF, Robinson GM, French JM, O’Connell JE, Alberti KG, Gray CS. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: The Glucose Insulin in Stroke Trial (GIST). Stroke 1999;30:793-9.
63. Scott JF, Robinson GM, French JM, O’Connell JE, Alberti KG, Gray CS. Blood pressure response to glucose potassium insulin therapy in patients with acute stroke with mild to moderate hyperglycaemia. J Neurol Neurosurg Psychiatry 2001;70:401-4.
64. Yang YG, Jiang DM, Quan ZX, Ou YS. Insulin with chondroitinase ABC treats the rat model of acute spinal cord injury. J Int Med Res 2009;37:1097-107.